Edition:
United States

ReShape Lifesciences Inc (RSLS.OQ)

RSLS.OQ on NASDAQ Stock Exchange Capital Market

1.50USD
17 Jul 2018
Change (% chg)

-- (--)
Prev Close
$1.50
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
41,266
52-wk High
$78.00
52-wk Low
$1.33

Select another date:

Mon, Jun 4 2018

UPDATE 1-FDA reports 5 more deaths related to intragastric balloons

June 4 The U.S. Food and Drug Administration on Monday notified healthcare providers that it had received reports of five more deaths in patients using liquid-filled intragastric balloon systems to treat obesity, bringing the total death toll to 12 since 2016.

BRIEF-Reshape Lifesciences Files For Mixed Shelf Of Up To $125 Mln

* RESHAPE LIFESCIENCES FILES FOR MIXED SHELF OF UP TO $125 MILLION - SEC FILING Source text: (https://bit.ly/2Ljt5n1) Further company coverage:

BRIEF-ReShape Lifesciences Qtrly Loss Per Share $0.36

* RESHAPE LIFESCIENCES ANNOUNCES RECORD REVENUE FOR FIRST QUARTER 2018

BRIEF-Reshape Lifesciences Announces Submission For Approval Of Reshape Balloon In Canada

* RESHAPE LIFESCIENCES ANNOUNCES SUBMISSION FOR APPROVAL OF RESHAPE BALLOON™ IN CANADA Source text for Eikon: Further company coverage:

BRIEF-Bobby Griffin To Retire From Reshape Lifesciences' Board

* RESHAPE LIFESCIENCES - ANNOUNCED THAT BOBBY I. GRIFFIN WILL RETIRE FROM BOARD OF DIRECTORS

BRIEF-Reshape Lifesciences Says Reshape Balloon Granted Registration By National Health Regulation Authority In Kingdom Of Bahrain

* RESHAPE LIFESCIENCES INC - RESHAPE BALLOON GRANTED REGISTRATION BY NATIONAL HEALTH REGULATION AUTHORITY IN KINGDOM OF BAHRAIN

BRIEF-Reshape Lifesciences Reports Qtrly Loss Per Share Of $0.45‍​

* RESHAPE LIFESCIENCES ANNOUNCES FOURTH QUARTER AND YEAR END 2017 FINANCIAL RESULTS

BRIEF-Reshape Lifesciences Announces $6 Million Registered Direct Offering

* RESHAPE LIFESCIENCES ANNOUNCES $6 MILLION REGISTERED DIRECT OFFERING Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)

BRIEF-Reshape Lifesciences Reschedules Fourth Quarter And Full Year 2017 Conference Call To April 2, 2018

* RESHAPE LIFESCIENCES ANNOUNCES UPDATE ON INTEGRATION EFFORTS AND RESCHEDULES FOURTH QUARTER AND FULL YEAR 2017 CONFERENCE CALL TO APRIL 2, 2018

BRIEF-ReShape Lifesciences Agrees With Academy Medical To Provide Reshape Balloon To Department Of Defense Facilities

* RESHAPE LIFESCIENCES ANNOUNCES AGREEMENT WITH ACADEMY MEDICAL TO PROVIDE RESHAPE BALLOON AND RESHAPE VBLOC TO DEPARTMENT OF DEFENSE FACILITIES

Select another date: